Cargando…

New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond

Lung cancer is the leading cause of mortality worldwide. Non-small cell lung cancer (NSCLC) is a particularly aggressive cancer, the optimum management of which is still being determined. In the metastatic disease, the standard therapy is a platinum-based combination chemotherapy; however, in spite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gori, Bruno, Ricciardi, Serena, Fulvi, Alberto, Intagliata, Salvatore, Signore, Ester Del, de Marinis, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253753/ https://www.ncbi.nlm.nih.gov/pubmed/22241943 http://dx.doi.org/10.2147/TCRM.S22079

Ejemplares similares

Efficacy of BIBF 1120 or BIBF 1120 plus chemotherapy on nasopharyngeal carcinoma in vitro and in vivo
por: Xue, Cong, et al.
Publicado: (2016)

Nintedanib (BIBF 1120) for IPF: a tomorrow therapy?
por: Antoniu, Sabina A
Publicado: (2012)

BIBF1120 Protects against Diabetic Retinopathy through Neovascularization-Related Molecules and the MAPK Signaling Pathway
por: Cao, Xin, et al.
Publicado: (2023)

PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120
por: Fazio, Grazia, et al.
Publicado: (2022)

Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients
por: Bousquet, G, et al.
Publicado: (2011)

Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl(4)-induced liver fibrogenesis mouse model
por: Öztürk Akcora, Büsra, et al.
Publicado: (2017)

Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)
por: Huang, Ruby Yun-Ju, et al.
Publicado: (2015)

Proteinuria and glomerular injury associated with the anti-angiogenesis drug Vargatef™
por: Manjunath, Veena, et al.
Publicado: (2011)

Sunitinib: the antiangiogenic effects and beyond
por: Hao, Zhonglin, et al.
Publicado: (2016)

Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer
por: Ricciardi, Serena, et al.
Publicado: (2009)

P1120: THE EFFICACY AND SAFETY OF ZANUBRUTINIB AND DEXAMETHASONE IN SYMPTOMATIC WALDENSTROM MACROGLOBULINNEMIA
por: Liu, A., et al.
Publicado: (2022)

New 11,20-Epoxybriaranes from the Gorgonian Coral Junceella fragilis (Ellisellidae)
por: Lin, Chia-Cheng, et al.
Publicado: (2019)

Abstract: 11.20 The Potential Of Adipose Derived Stem Cells For Chronic Wounds
por: Rafik, Amine, et al.
Publicado: (2017)

MET in Non-Small-Cell Lung Cancer (NSCLC): Cross ‘a Long and Winding Road’ Looking for a Target
por: Spitaleri, Gianluca, et al.
Publicado: (2023)

Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running?
por: Spitaleri, Gianluca, et al.
Publicado: (2023)

Triple-tyrosine kinase inhibition by BIBF1000 attenuates airway and pulmonary arterial remodeling following chronic allergen challenges in mice
por: Gurusamy, Malarvizhi, et al.
Publicado: (2023)

Abstract: 11.20 Prior Radiotherapy Does Not Affect Abdominal Wall Reconstruction Nor Ventral Hernia Repair Outcomes
por: Giordano, Salvatore, et al.
Publicado: (2017)

1120. Reliability of Parent-Reported Pediatric Antibiotic Use in a Longitudinal Birth Cohort
por: D’Arinzo, Lauren, et al.
Publicado: (2019)

Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis
por: De Santis, Stefano, et al.
Publicado: (2016)

Evaluation of forensic and anthropological potential of D9S1120 in Mestizos and Amerindian populations from Mexico
por: Rangel-Villalobos, Héctor, et al.
Publicado: (2012)

1120. Impact of Training Residents to Improve HIV Screening in a Teaching Hospital in Mexico City
por: Guerrero-Torres, Lorena, et al.
Publicado: (2020)

New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations
por: Attili, Ilaria, et al.
Publicado: (2023)

Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50%
por: Attili, Ilaria, et al.
Publicado: (2022)

Novel Therapeutic Options for Solitary Fibrous Tumor: Antiangiogenic Therapy and Beyond
por: de Bernardi, Axel, et al.
Publicado: (2022)

11,20-Dihydroxy-3-oxopregna-1,4-dien-21-oic acid monohydrate
por: Guo, Zhanqiang, et al.
Publicado: (2011)

The outcomes of 1120 severe multiple trauma patients with hemorrhagic shock in an emergency department: a retrospective study
por: Wen, Yin, et al.
Publicado: (2013)

1120 The Impact of Influenza Vaccination in Patients with Cancer on Subsequent Disease during the 2013-2014 Influenza Season
por: Azzi, Jacques, et al.
Publicado: (2014)

1120. Descriptive Analysis of Monoclonal Antibody Administration for Pregnant Patients with SARS-CoV-2 Infection
por: Vikraman, Praveen Kumar, et al.
Publicado: (2022)

Advances in antiangiogenic treatment of small-cell lung cancer
por: Lu, Hongyang, et al.
Publicado: (2017)

Retrospective analyses of trends in pancreatic surgery: indications, operative techniques, and postoperative outcome of 1,120 pancreatic resections
por: Wittel, Uwe A, et al.
Publicado: (2015)

Fragilides U–W: New 11,20-Epoxybriaranes from the Sea Whip Gorgonian Coral Junceella fragilis
por: Su, Tung-Pin, et al.
Publicado: (2019)

Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional Survey
por: Catania, Chiara, et al.
Publicado: (2020)

Antiangiogenic therapy
por: Avitabile, T
Publicado: (2010)

NOSH-aspirin (NBS-1120), a dual nitric oxide and hydrogen sulfide-releasing hybrid, reduces inflammatory pain
por: Fonseca, Miriam D, et al.
Publicado: (2015)

P1120: NOVEL TARGETED AGENTS IN COMBINATION WITH R-ICE (R-ICE-X) BASED ON GENOTYPING IN RELAPSED/REFRACTORY DLBCL.
por: Yige, Shen, et al.
Publicado: (2023)

The inefficacy of antiangiogenic therapies
por: Ribatti, Domenico
Publicado: (2010)

Antiangiogenic Therapy for Glioma
por: Cea, Valentina, et al.
Publicado: (2012)

Antiangiogenic Cancer Therapy
por: Maxwell, P H, et al.
Publicado: (2009)

Antiangiogenic effects of oridonin
por: Tian, Lili, et al.
Publicado: (2017)

Antiangiogenic Effect of Alkaloids
por: Alasvand, Masoud, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4ib9i8h1th4i7tht21akk93o4e